Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Dietrich, CF, Nolsøe, CP, Barr, RG, Berzigotti, A, Burns, PN, Cantisani, V, Chammas, MC, Chaubal, N, Choi, BI, Clevert, D-A, Cui, X, Dong, Y, D'Onofrio, M, Fowlkes, JB, Gilja, OH, Huang, P, Ignee, A, Jenssen, C, Kono, Y, Kudo, M, Lassau, N, Lee, WJ, Lee, JY, Liang, P, Lim, A, Lyshchik, A, Meloni, MF, Correas, JM, Minami, Y, Moriyasu, F, Nicolau, C, Piscaglia, F, Saftoiu, A, Sidhu, PS, Sporea, I, Torzilli, G, Xie, X & Zheng, R 2020, 'Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS', Ultrasound in Medicine & Biology, vol. 46, no. 10, pp. 2579-2604. https://doi.org/10.1016/j.ultrasmedbio.2020.04.030

APA

Dietrich, C. F., Nolsøe, C. P., Barr, R. G., Berzigotti, A., Burns, P. N., Cantisani, V., Chammas, M. C., Chaubal, N., Choi, B. I., Clevert, D-A., Cui, X., Dong, Y., D'Onofrio, M., Fowlkes, J. B., Gilja, O. H., Huang, P., Ignee, A., Jenssen, C., Kono, Y., ... Zheng, R. (2020). Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound in Medicine & Biology, 46(10), 2579-2604. https://doi.org/10.1016/j.ultrasmedbio.2020.04.030

CBE

Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, Chammas MC, Chaubal N, Choi BI, Clevert D-A, Cui X, Dong Y, D'Onofrio M, Fowlkes JB, Gilja OH, Huang P, Ignee A, Jenssen C, Kono Y, Kudo M, Lassau N, Lee WJ, Lee JY, Liang P, Lim A, Lyshchik A, Meloni MF, Correas JM, Minami Y, Moriyasu F, Nicolau C, Piscaglia F, Saftoiu A, Sidhu PS, Sporea I, Torzilli G, Xie X, Zheng R. 2020. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound in Medicine & Biology. 46(10):2579-2604. https://doi.org/10.1016/j.ultrasmedbio.2020.04.030

MLA

Vancouver

Author

Dietrich, Christoph F ; Nolsøe, Christian Pállson ; Barr, Richard G ; Berzigotti, Annalisa ; Burns, Peter N ; Cantisani, Vito ; Chammas, Maria Cristina ; Chaubal, Nitin ; Choi, Byung Ihn ; Clevert, Dirk-André ; Cui, Xinwu ; Dong, Yi ; D'Onofrio, Mirko ; Fowlkes, J Brian ; Gilja, Odd Helge ; Huang, Pintong ; Ignee, Andre ; Jenssen, Christian ; Kono, Yuko ; Kudo, Masatoshi ; Lassau, Nathalie ; Lee, Won Jae ; Lee, Jae Young ; Liang, Ping ; Lim, Adrian ; Lyshchik, Andrej ; Meloni, Maria Franca ; Correas, Jean Michel ; Minami, Yasunori ; Moriyasu, Fuminori ; Nicolau, Carlos ; Piscaglia, Fabio ; Saftoiu, Adrian ; Sidhu, Paul S ; Sporea, Ioan ; Torzilli, Guido ; Xie, Xiaoyan ; Zheng, Rongqin. / Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. In: Ultrasound in Medicine & Biology. 2020 ; Vol. 46, No. 10. pp. 2579-2604.

Bibtex

@article{89de3aef67174b709aef213bb7da7076,
title = "Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS",
abstract = "The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast-enhanced ultrasound, first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology. The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications. The 2012 guideline requires updating as, previously, the differences in the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including U.S. Food and Drug Administration approval and the extensive Asian experience, to produce a truly international perspective. These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCAs) and are intended to create standard protocols for the use and administration of UCAs in liver applications on an international basis to improve the management of patients.",
author = "Dietrich, {Christoph F} and Nols{\o}e, {Christian P{\'a}llson} and Barr, {Richard G} and Annalisa Berzigotti and Burns, {Peter N} and Vito Cantisani and Chammas, {Maria Cristina} and Nitin Chaubal and Choi, {Byung Ihn} and Dirk-Andr{\'e} Clevert and Xinwu Cui and Yi Dong and Mirko D'Onofrio and Fowlkes, {J Brian} and Gilja, {Odd Helge} and Pintong Huang and Andre Ignee and Christian Jenssen and Yuko Kono and Masatoshi Kudo and Nathalie Lassau and Lee, {Won Jae} and Lee, {Jae Young} and Ping Liang and Adrian Lim and Andrej Lyshchik and Meloni, {Maria Franca} and Correas, {Jean Michel} and Yasunori Minami and Fuminori Moriyasu and Carlos Nicolau and Fabio Piscaglia and Adrian Saftoiu and Sidhu, {Paul S} and Ioan Sporea and Guido Torzilli and Xiaoyan Xie and Rongqin Zheng",
note = "Copyright {\textcopyright} 2020 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.",
year = "2020",
month = oct,
doi = "10.1016/j.ultrasmedbio.2020.04.030",
language = "English",
volume = "46",
pages = "2579--2604",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier Inc",
number = "10",

}

RIS

TY - JOUR

T1 - Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS

AU - Dietrich, Christoph F

AU - Nolsøe, Christian Pállson

AU - Barr, Richard G

AU - Berzigotti, Annalisa

AU - Burns, Peter N

AU - Cantisani, Vito

AU - Chammas, Maria Cristina

AU - Chaubal, Nitin

AU - Choi, Byung Ihn

AU - Clevert, Dirk-André

AU - Cui, Xinwu

AU - Dong, Yi

AU - D'Onofrio, Mirko

AU - Fowlkes, J Brian

AU - Gilja, Odd Helge

AU - Huang, Pintong

AU - Ignee, Andre

AU - Jenssen, Christian

AU - Kono, Yuko

AU - Kudo, Masatoshi

AU - Lassau, Nathalie

AU - Lee, Won Jae

AU - Lee, Jae Young

AU - Liang, Ping

AU - Lim, Adrian

AU - Lyshchik, Andrej

AU - Meloni, Maria Franca

AU - Correas, Jean Michel

AU - Minami, Yasunori

AU - Moriyasu, Fuminori

AU - Nicolau, Carlos

AU - Piscaglia, Fabio

AU - Saftoiu, Adrian

AU - Sidhu, Paul S

AU - Sporea, Ioan

AU - Torzilli, Guido

AU - Xie, Xiaoyan

AU - Zheng, Rongqin

N1 - Copyright © 2020 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

PY - 2020/10

Y1 - 2020/10

N2 - The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast-enhanced ultrasound, first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology. The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications. The 2012 guideline requires updating as, previously, the differences in the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including U.S. Food and Drug Administration approval and the extensive Asian experience, to produce a truly international perspective. These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCAs) and are intended to create standard protocols for the use and administration of UCAs in liver applications on an international basis to improve the management of patients.

AB - The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast-enhanced ultrasound, first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology. The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications. The 2012 guideline requires updating as, previously, the differences in the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including U.S. Food and Drug Administration approval and the extensive Asian experience, to produce a truly international perspective. These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCAs) and are intended to create standard protocols for the use and administration of UCAs in liver applications on an international basis to improve the management of patients.

U2 - 10.1016/j.ultrasmedbio.2020.04.030

DO - 10.1016/j.ultrasmedbio.2020.04.030

M3 - Review

C2 - 32713788

VL - 46

SP - 2579

EP - 2604

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 10

ER -

ID: 61228029